For example, the gene encoding protease urokinase-type plasminogen activator (PLAU/uPA) is hypomethylated and over expressed in conjugation with tumour progression in breast cancers, with increased uPA expression resulting in increased tumour aggression and poor clinical outcome [102, 103]. The gene discussed is PLAU; the disease is breast cancer.